BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1344 related articles for article (PubMed ID: 16283795)

  • 21. Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods.
    Rovero P; Quartara L; Fabbri G
    Int J Pept Protein Res; 1991 Feb; 37(2):140-4. PubMed ID: 1850390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors.
    Freeman NS; Tal-Gan Y; Klein S; Levitzki A; Gilon C
    J Org Chem; 2011 May; 76(9):3078-85. PubMed ID: 21410283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramolecular pyrophosphate formation during N alpha-9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase synthesis of peptides containing adjacent phosphotyrosine residues.
    Ottinger EA; Xu Q; Barany G
    Pept Res; 1996; 9(5):223-8. PubMed ID: 9000247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramolecular quenching of tryptophan phosphorescence in short peptides and proteins.
    Gonnelli M; Strambini GB
    Photochem Photobiol; 2005; 81(3):614-22. PubMed ID: 15689181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR and computer-aided modeling studies of the interactions between a cyclic hexapeptide and the two enantiomers of some Boc- and Fmoc-amino acids.
    McEwen I
    Biopolymers; 1993 Jun; 33(6):933-42. PubMed ID: 8318666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pH, urea, peptide length, and neighboring amino acids on alanine alpha-proton random coil chemical shifts.
    Carlisle EA; Holder JL; Maranda AM; de Alwis AR; Selkie EL; McKay SL
    Biopolymers; 2007 Jan; 85(1):72-80. PubMed ID: 17054116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3(10)-helical pentapeptide in water: interplay of alpha,alpha-disubstituted amino acids and the central residue on structure formation.
    Wang J; McElheny D; Fu Y; Li G; Kim J; Zhou Z; Wu L; Keiderling TA; Hammer RP
    Biopolymers; 2009; 92(5):452-64. PubMed ID: 19489061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBTU activation for automated Fmoc solid-phase peptide synthesis.
    Fields CG; Lloyd DH; Macdonald RL; Otteson KM; Noble RL
    Pept Res; 1991; 4(2):95-101. PubMed ID: 1815783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase synthesis of N-nosyl- and N-Fmoc-N-methyl-alpha-amino acids.
    Di Gioia ML; Leggio A; Liguori A; Perri F
    J Org Chem; 2007 May; 72(10):3723-8. PubMed ID: 17439178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and structure-activity relationships of novel alpha-melanocyte-stimulating hormone inhibitors.
    Sawyer TK; Staples DJ; Castrucci AM; Hadley ME
    Pept Res; 1989; 2(1):140-6. PubMed ID: 2562482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds.
    Norgren AS; Büttner F; Prabpai S; Kongsaeree P; Arvidsson PI
    J Org Chem; 2006 Sep; 71(18):6814-21. PubMed ID: 16930031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis.
    Biron E; Kessler H
    J Org Chem; 2005 Jun; 70(13):5183-9. PubMed ID: 15960522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucosylthioureidocalix[4]arenes: Synthesis, conformations and gas phase recognition of amino acids.
    Torvinen M; Neitola R; Sansone F; Baldini L; Ungaro R; Casnati A; Vainiotalo P; Kalenius E
    Org Biomol Chem; 2010 Feb; 8(4):906-15. PubMed ID: 20135051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, isolation, and characterization of Nalpha-Fmoc-peptide isocyanates: solution synthesis of oligo-alpha-peptidyl ureas.
    Sureshbabu VV; Patil BS; Venkataramanarao R
    J Org Chem; 2006 Sep; 71(20):7697-705. PubMed ID: 16995676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
    Felix AM; Lu YA; Campbell RM
    Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.